CN112386682A - 纤连蛋白在制备治疗新型冠状病毒肺炎药物中的应用 - Google Patents
纤连蛋白在制备治疗新型冠状病毒肺炎药物中的应用 Download PDFInfo
- Publication number
- CN112386682A CN112386682A CN202110035328.7A CN202110035328A CN112386682A CN 112386682 A CN112386682 A CN 112386682A CN 202110035328 A CN202110035328 A CN 202110035328A CN 112386682 A CN112386682 A CN 112386682A
- Authority
- CN
- China
- Prior art keywords
- fibronectin
- liquid preparation
- use according
- application
- new
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Otolaryngology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Oncology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
临床症状 | 临床效果观察 |
呼吸困难 | 减轻 |
咳嗽 | 减轻 |
咳痰 | 减轻 |
肺部渗出液 | 减少 |
排痰 | 顺畅 |
肺部CT影响 | 病灶减少 |
Claims (6)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010087751 | 2020-02-12 | ||
CN2020100877517 | 2020-02-12 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112386682A true CN112386682A (zh) | 2021-02-23 |
CN112386682B CN112386682B (zh) | 2022-12-06 |
Family
ID=74624866
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110035328.7A Active CN112386682B (zh) | 2020-02-12 | 2021-01-12 | 纤连蛋白在制备治疗新型冠状病毒肺炎药物中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112386682B (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011097401A1 (en) * | 2010-02-03 | 2011-08-11 | University Of Rochester | Treatment of fibrosis-related disorders using fibronectin binding proteins and polypeptides |
CN104491845A (zh) * | 2008-04-18 | 2015-04-08 | 科尔普兰特有限公司 | 产生和使用原胶原的方法 |
CN108014340A (zh) * | 2011-04-12 | 2018-05-11 | 莫伊莱麦屈克斯公司 | 用于预防或治疗以成纤维细胞异常增殖及细胞外基质沉积为特征的疾病的组合物和方法 |
-
2021
- 2021-01-12 CN CN202110035328.7A patent/CN112386682B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104491845A (zh) * | 2008-04-18 | 2015-04-08 | 科尔普兰特有限公司 | 产生和使用原胶原的方法 |
WO2011097401A1 (en) * | 2010-02-03 | 2011-08-11 | University Of Rochester | Treatment of fibrosis-related disorders using fibronectin binding proteins and polypeptides |
CN108014340A (zh) * | 2011-04-12 | 2018-05-11 | 莫伊莱麦屈克斯公司 | 用于预防或治疗以成纤维细胞异常增殖及细胞外基质沉积为特征的疾病的组合物和方法 |
Non-Patent Citations (4)
Title |
---|
ERIC S WHITE ET AL.: "Fibronectin Splice Variants: Understanding Their Multiple Roles in Health and Disease Using Engineered Mouse Models", 《IUBMB LIFE》 * |
刘旭之等: "纤连蛋白(FN) 雾化吸入治疗COVID-19的临床效果观察", 《基础医学与临床》 * |
王正国等: "《分子创伤学》", 31 August 2004, 福建科学技术出版社 * |
金惠铭: "《临床病理生理学》", 30 November 1999, 上海医科大学出版社 * |
Also Published As
Publication number | Publication date |
---|---|
CN112386682B (zh) | 2022-12-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Pocsfalvi et al. | COVID-19 and extracellular vesicles: an intriguing interplay | |
CN111265500B (zh) | 一种防治covid-19的药物组合物及其制备方法 | |
CN112386595A (zh) | 一种治疗呼吸系统病毒性感染的药物组合物 | |
US20170202919A1 (en) | Methods for preventing or treating optic neuritis | |
EP4268841A1 (en) | Antiviral agent for combined therapy of covid-19 (sars-cov-2) | |
WO2022199049A1 (zh) | 乌司他丁在制备治疗新型冠状病毒肺炎药物中的用途 | |
CN107551095B (zh) | 一种利用干细胞提取物和中药提取物混合制备的银屑病皮肤修复剂 | |
US20080260863A1 (en) | Compositions for mucociliary clearance and methods for administering same | |
CN112386682B (zh) | 纤连蛋白在制备治疗新型冠状病毒肺炎药物中的应用 | |
RU2353376C1 (ru) | Способ лечения и профилактики бронхопневмонии у телят и поросят | |
CN115209954B (zh) | 用于治疗呼吸系统病变的组合物 | |
RU2745986C1 (ru) | Противокоронавирусное средство для комбинированной терапии COVID-19 (SARS-CoV-2) и способ лечения | |
CN114672456A (zh) | 利用超声刺激提高脂肪干细胞分泌胞外囊泡效率的方法及应用 | |
CN113384688A (zh) | 一种糜蛋白酶在抗冠状病毒中的应用 | |
US20170136101A1 (en) | Methods for preventing and/or treating nasal polyps and rhinosinusitis | |
Tamis et al. | Potentials of Stem Cell Therapy in Patients Infected with COVID-19: A Systematic Review | |
RU2742116C1 (ru) | Противокоронавирусное средство для комбинированной терапии COVID-19 (SARS-CoV-2). | |
EP4051307B1 (en) | Peptide for prevention or treatment of covid-19 | |
CN111214495B (zh) | 注射用母牛分枝杆菌在制备用于防治呼吸系rsv感染的药物中的应用 | |
CN111281893B (zh) | 注射用母牛分枝杆菌在制备用于防治covid-19的药物中的应用 | |
CN111249300B (zh) | 褪黑素联合甲钴胺在治疗糖尿病创面愈合障碍中的应用 | |
RU2746161C1 (ru) | Фармацевтический набор для комбинированной терапии COVID-19 (SARS-CoV-2) и способ его применения | |
CN107970237A (zh) | 艾瑞昔布在制备治疗肺纤维化药物中的应用 | |
US20230201309A1 (en) | Compositions for the treatment of a respiratory condition | |
US20210346459A1 (en) | Application of Dalargin for the prevention of VRIs and prevention of the development of complications during VRIs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Zhang Shiyang Inventor after: Wang Haoqing Inventor after: Wang Bing Inventor after: Luo Kangshuai Inventor after: Wang Bin Inventor after: Guo Fengling Inventor after: Ma Zhe Inventor after: Yang Minqi Inventor after: Jia Xiuxiu Inventor after: Shen Weijia Inventor after: Yu Fengxia Inventor after: Shen Hong Inventor before: Wang Bin Inventor before: Wang Haoqing Inventor before: Wang Bing Inventor before: Luo Kangshuai Inventor before: Zhang Shiyang Inventor before: Guo Fengling Inventor before: Ma Zhe Inventor before: Yang Minqi Inventor before: Jia Xiuxiu Inventor before: Shen Weijia Inventor before: Yu Fengxia Inventor before: Shen Hong |
|
CB03 | Change of inventor or designer information | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20221020 Address after: 450003 No.5, Building 29, yard 66, Tianming Road, Jinshui District, Zhengzhou City, Henan Province Applicant after: Wang Bin Address before: 201306 C, 888, west two road, Nanhui new town, Pudong New Area, Shanghai Applicant before: Shanghai xianrui Biotechnology Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant |